SCHEMBL29630763

SCHEMBL29630763

CSCC[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)O

nearest known ligand 0.51

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
▸ NPY4R P50391 5/20 0.51
▸ NPY1R P25929 4/20 0.51
▸ NPY2R P49146 3/20 0.51
▸ ENPEP Q07075 5/20 0.46
▸ BACE1 P56817 3/20 0.46
▸ NPY5R Q15761 2/20 0.45
▸ BACE2 Q9Y5Z0 1/20 0.44
▸ NAALAD2 Q9Y3Q0 1/20 0.43
▸ KISS1R Q969F8 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29630684 0.91 NPY1R (0.49) NPY4RNPY1RNPY2RBACE1NAALAD2
SCHEMBL29630527 0.91 NPY4R (0.54) NPY4RNPY1RNPY2RENPEPBACE1
SCHEMBL29591795 0.91 NPY4R (0.54) NPY4RNPY1RNPY2RENPEPBACE1
SCHEMBL29883948 0.90 NPY4R (0.57) NPY4RNPY1RNPY2RBACE1NPY5R
SCHEMBL29630373 0.89 NPY1R (0.52) NPY4RNPY1RNPY2RENPEPNAALAD2
SCHEMBL30516168 0.89 NPY4R (0.53) NPY4RNPY1RNPY2RENPEPBACE1
SCHEMBL29591841 0.89 BACE1 (0.52) BACE1BACE2
SCHEMBL31711265 0.88 BACE1 (0.58) NPY4RNPY1RNPY2RBACE1BACE2
SCHEMBL29567343 0.88 NPY1R (0.50) NPY4RNPY1RNPY2RENPEPBACE1
SCHEMBL30311095 0.88 ENPEP (0.57) NPY4RNPY1RNPY2RENPEPBACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11807899-B2 Biochemical reaction methods and reagents comprising intrinsically disordered regions Biocrucible Limited 2023-11-07 — — US disclosed
US-20220145378-A1 BIOCHEMICAL REACTION METHODS AND REAGENTS COMPRISING INTRINSICALLY DISORDERED REGIONS Biocrucible Limited (GB) 2022-05-12 — — US disclosed
Send feedback